Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

ITRM holding history

Iterum Therapeutics plc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITRM overviewAll 13F holders of ITRMFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
6
Since Q1 2021
Holdings of ITRM by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−21,207−100.0%Sold outHolders
Q4 202421,207$37.5K<0.1%+21,207NewHolders
Q4 20230$00.0%−19,566−100.0%Sold outHolders
Q3 202319,566$16.2K<0.1%+19,566NewHolders
Q2 20220$00.0%−50,515−100.0%Sold outHolders
Q1 202250,515$18.0K<0.1%+28,125+125.6%AddedHolders
Q4 202122,390$9.00K<0.1%+22,390NewHolders
Q3 20210$00.0%−69,354−100.0%Sold outHolders
Q2 202169,354$160.0K<0.1%−67,672−49.4%ReducedHolders
Q1 2021137,026$193.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.